Contact l Sitemap

home industries issues reasearch weblog press

Home  » Issues » Health

SOUTH AFRICA: S Africa bans Aids vitamin trials

BBC News
June 13th, 2008

A South African court has banned unauthorised trials of vitamin therapies for Aids, which some say are a health risk.

The High Court in Cape Town ruled against German physician Matthias Rath and US doctor David Rasnick, a former adviser to President Thabo Mbeki.

The case was brought by the pressure group the Treatment Action Campaign and the South African Medical Association.

They accused Dr Rath of conducting illegal trials among poor communities.

"It is declared that the clinical trials conducted in South Africa are unlawful," Judge Dumisani Zondi said in his ruling.

Matthias Rath and his Rath Foundation promote vitamin pills and minerals which they say can reverse the development of HIV/Aids.

But critics say such trials had led to unnecessary deaths when HIV-positive people stopped using anti-retroviral drugs.

TAC and SAMA accused the South African government of not doing enough to stop the trials and failing in its duty of care to the public.

Health Minister Manto Tshabalala-Msimang, who has controversially advocated garlic and beetroot instead of anti-retroviral drugs, denied the allegations.

Nathan Geffen of the Treatment Action Campaign hailed the judgment as a victory for scientific governance, which he said had been contested by the health minister and president.

South Africa has one of the world's highest incidences of HIV. One in five adults are reported to be infected and an estimated 500,000 people are infected each year.





This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.